Award
NIH Reporter #5R50CA252135-05
Improving Outcomes for Multiple Myeloma Patients through Novel Therapeutic Interventions
Recipient
Beckman Research Institute/City of Hope, Duarte, CA, United States
Award Amount
$112,893.00
Ceiling
$112,893.00
Awarded
August 21, 2025
Identifier
5R50CA252135-05
NIH-funded project focused on novel therapeutic interventions to improve outcomes for multiple myeloma patients, including radioimmunotherapy, oncovirus Reolysin, and drug resistance strategies.
Description
This project involves three NIH-funded studies aiming to improve therapeutic outcomes for multiple myeloma patients through innovative approaches including radioimmunotherapy/CAR T cells, Reolysin combined with proteasome inhibitors, and overcoming IMiD resistance with drug combinations.